Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection.
University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Qaiser
Q
Bashir
Lauren A
LA
Langford
Simrit
S
Parmar
Richard E
RE
Champlin
Muzaffar H
MH
Qazilbash
D000682:Amyloid / Q000032:analysis*; D000686:Amyloidosis / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D001341:Autonomic Nervous System / Q000503:physiopathology; D001781:Blood Component Removal / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology; D019650:Hematopoietic Stem Cell Mobilization / Q000009:adverse effects* / Q000379:methods; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000032:analysis*; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology; D011994:Recombinant Proteins; D014182:Transplantation, Autologous
D000682:Amyloid; D007147:Immunoglobulin Light Chains; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim